RecruitingNot ApplicableNCT04537390
Anti-mullerian Hormone Levels in Healthy Females
Sponsor
Erin Rowell
Enrollment
100 participants
Start Date
Jul 19, 2016
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to have a better understanding of the normal blood levels of AMH in females from 0-18 years of age and how the blood AMH levels correspond to a female's reproductive development.
Eligibility
Sex: FEMALEMax Age: 18 Years
Inclusion Criteria7
- Pre- and post-pubertal females
- Ages 0-18 years old
- Tanner Stage I- V
- Undergoing routine outpatient surgical procedure
- Hernia repair (inguinal, umbilical, epigastric)
- Excision of benign mass
- laparoscopic cholecystectomy
Exclusion Criteria10
- Previous diagnosis of an illness associated with premature ovarian failure (Turner's syndrome, Fragile X permutation carrier) or endocrine disorder associated with irregular menstrual cycles (Cushing's disease, poorly-controlled Thyroid disease, hyperprolactinemia, polycystic ovary syndrome, and congenital adrenal hyperplasia) or insulin-dependent diabetes mellitus or autoimmune disorders
- Previous diagnosis of any malignancy or any history of systemic/local chemotherapy, radiation therapy, or stem-cell transplant.
- Previous surgical excision of one ovary or both ovaries
- Pregnant females
- All inpatient surgical patients
- Undergoing non-routine outpatient surgical procedures
- Central venous catheter placement
- Supprelin insertion/removal
- Breast mass excision
- Gastrostomy tube insertion
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTBlood sample collection
Blood samples are collected for diagnostically assessing how the blood AMH levels correspond to a female's reproductive development
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04537390
Related Trials
PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
NCT071696301 location
Predicting Future Errors During Skill Performance
NCT067072071 location
The ENHANCE Study: taVNS and Psilocybin
NCT058664711 location
Resistance Training and Rapamycin to Enhance Bone Formation in Postmenopausal Women
NCT071913532 locations
Selective PET Imaging of Astrocytes and Microglia in Alzheimer's Disease
NCT055822001 location